alexa
Reach Us +44-1764910199
Treatment of Lyme Diseasewith Human Embryonic Stem Cells: A Case Series | OMICS International | Abstract
E-ISSN: 2314-7326
P-ISSN: 2314-7334

Journal of Neuroinfectious Diseases
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Case Report

Treatment of Lyme Diseasewith Human Embryonic Stem Cells: A Case Series

Geeta Shroff*

Director, NutechMediworld, New Delhi, India

*Corresponding Author:
GeetaShroff
NutechMediworld, H-8 Green Park Extension
New Delhi-110016 India
Tel: +91 11 26565548
Fax: +91 11 46057841
E-mail: [email protected]

Received January 20, 2015; Accepted February 28, 2015; Published March 3, 2015

Citation: Shroff G (2015) Treatment of Lyme Diseasewith Human Embryonic Stem Cells: A Case Series. J Neuroinfect Dis 6:167. doi:

Copyright: ©2015Shroff G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Background: Lyme Disease (LD) is a tick-borne disease caused by Borreliaburgdorferi (Bb) and transmitted in humans by Ixodesscapularis. LD can affect any organ of the body. The present study evaluated the efficacy and safety of human embryonic stem cell (hESC) therapy for the treatment of LD.

Methods: Patients included in the present study had experienced symptoms of LD to varying degree of severities and intensities. The study consisted of treatment phases separated by gap phases in-between.

Results: Improvement in symptoms was observed receiving hESC therapy. hESC therapy showed considerable improvement in the condition of the patients who were unable to walk straight or maintain balance while sitting and standing. These patients had regained their balance and had started to perform their regular activities with less effort after receiving hESC therapy. In addition, patients showed improvement in blurred vision, tremors, had higher energy levels, improved stamina, appetite, decreased numbness in the upper limb, decreased stiffness, regained balance, and had no slurring of speech after receiving hESC therapy.

Conclusion: In conclusion, hESC therapy has shown significant improvement in patients with LD. Improvement in patients was observed without any adverse events.

Keywords

Top